Global healthcare expenditure is escalating at an unsustainable rate. Money spent on
medicines and managing medication-related problems continues to grow. The high …

Background Chronic disease represents a significant burden to the United States (US)
health care system, with approximately 50% of all adults in the US having one or more …

Team-based cardiovascular care, including the use of clinical pharmacists, can efficiently
deliver high-quality care. This Joint Council Perspectives paper from the Cardiovascular …

The American College of Clinical Pharmacy (ACCP) previously published position
statements on collaborative drug therapy management (CDTM) in 1997 and 2003. Since …

Background Clinical and cost-effectiveness evidence are needed to justify the existence or
extension of routine clinical pharmacy services in hospital settings. Previous reviews have …

A growing body of research demonstrates the effectiveness of evidence-based pharmacy
practice, but too many practice innovations fail to survive past the initial implementation and …

What is known and objectives Most antineoplastic drugs are highly toxic and have low
therapeutic indexes, which can result in drug‐related problems. In this context, pharmacist …

In the past years, several factors such as evidence-based healthcare culture, quality-linked
incentives, and patient-centered actions, associated with an important increase of financial …

There has never been a greater need for people to access high-quality expertise about the
effectiveness, safety and use of medications. While drugs improve health and save lives …

Background Drug related problems have a significant clinical and economic burden on
patients and the healthcare system. Medication review with follow-up (MRF) is a …